Leukemia Clinical Trials

Showing 4281-4300 of 8,366 trials

Immune Boost In Non-Small Cell Lung Cancer

NCT02319408

Insufficient migration and activation of tumour specific effector T cells seems to be the one important reason for inadequate host anti-tumour immune response. Ionizing radiation can induce a variety of immune responses. The goal of this randomized trial is to assess if a preoperative single fraction low dose radiation is able to improve anti-tumour immune response in operable early stage lung cancer.

Non-small Cell Lung Cancer

University Hospital Heidelberg36 participantsStarted Apr 2016

Heidelberg, Germany • Heidelberg, Germany

WITHDRAWNPhase 2

A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

NCT04264806

The purpose of the study is to compare overall response rate (ORR) between treatment groups in participants with higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) who are not eligible for Hematopoietic Stem Cell Transplantation (HSCT).

Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic

Janssen Research & Development, LLCStarted May 2021

Darlinghurst, Australia • Fitzroy, Australia • Melbourne, Australia +70 more locations

Immune Boost In Non-Small Cell Lung Cancer

A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

Related Searches

Outcome Following Truncation of Asparaginase

Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy

Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer

Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers

Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL

Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.

Clinical Characteristics and Outcomes of Pediatric COVID-19

Chinese Version of LIVE-LiFE for Older Adults With Previous Falls

Dose Individualization of Pemetrexed - IMPROVE-II

The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib

Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer

AF CRT +/- Nimorazole in HNSCC

Metabolomic Analysis of Lung Cancer

FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer

Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation